Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Copper Catalyzed Coupling. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101563312A details a cost-effective route to Asenapine intermediates using 2-chlorophenylacetic acid, offering significant supply chain advantages for API manufacturers.
Optimized synthesis of 2-(4-ethyl-3-iodophenyl)-2-methylpropanoic acid via copper catalysis. Reduces heavy metal residue and cost for API manufacturing.
Novel copper-catalyzed route for 4-bromocarbazole offers high yield and cost efficiency for display material supply chains and pharmaceutical intermediates.
Patent CN106278965B details a copper-catalyzed method for aryl-alkyl asymmetric persulfides. This report analyzes cost reduction and supply chain advantages for pharmaceutical manufacturing.
Patent CN102875444A details a Cu-catalyzed route for oxindoles. Offers high purity, mild conditions, and scalable manufacturing for pharma intermediates.
Patent CN107253925A reveals copper-catalyzed decarboxylative coupling for high-purity insecticide intermediates, offering scalable supply chain solutions and significant cost reduction in agrochemical manufacturing.
Novel catalytic method enhances benzamide compound purity and yield. Offers significant supply chain stability and cost reduction in API manufacturing for global partners.
Patent CN113912556B reveals a novel Cu-catalyzed oxidative coupling route for alpha,beta-dicarbonyl-1,2,3-triazoles, offering significant cost reduction in API manufacturing.
Novel synthesis of perfluoroalkyl aromatic hydroxylamine via copper-catalyzed coupling. High-purity intermediate for fluorocarbon catalysts and pharmaceutical applications.
Patent CN107235910B reveals a high-purity synthesis route for Nilotinib intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.
Patent CN112939829A reveals a copper-catalyzed method for aryl trifluoromethyl thioethers, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel copper-catalyzed radical coupling method for polysubstituted pyrrolidines offers high yield and mild conditions for CNS drug intermediate manufacturing.
Patent CN112341468A reveals a novel copper-catalyzed route to azetidino-1,4-benzodiazepines, offering high yields and streamlined functionalization for API manufacturing.
Novel four-component coupling method for high-purity maleimide intermediates offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN108276300B reveals a copper-catalyzed route for high-purity biphenyl triarylamine hole transport materials, offering significant cost reduction and scalability.
Patent CN110183379A details a copper-catalyzed one-pot method for C-4 sulfone isoquinolinones, offering cost reduction and supply chain reliability for pharma intermediates.
Patent CN101792438A details a copper-catalyzed decarboxylative coupling for high-purity triazole intermediates, offering cost-effective manufacturing solutions.
Patent CN116751219A enables high-purity 1,3-conjugated butadiene derivatives. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Novel 2-step synthesis of bifenazate using copper catalysis offers high yield and safety. Ideal for agrochemical intermediate manufacturing scale-up.
Patent CN111978237A details a novel Cu-catalyzed four-component coupling for high-purity maleimide intermediates, offering significant cost reduction and supply chain reliability.